Clinical trial
Orlistat Treatment of Crigler-Najjar Disease
NCT00461799 · University Medical Center Groningen, Other · Completed
Key facts
| NCT number | NCT00461799 |
|---|---|
| Title | Orlistat Treatment of Crigler-Najjar Disease |
| Official title | Orlistat Treatment of Unconjugated Hyperbilirubinemia in Crigler-Najjar Disease; A Randomized Controlled Trial |
| Lead sponsor | University Medical Center Groningen, Other |
| Collaborators | Erasmus Medical Center De Najjar Stichting |
| Status | Completed |
| Study type | Interventional |
| Conditions | Crigler-Najjar Syndrome |
| Intervention type | Drug |
| Interventions | orlistat |
| Enrollment | 16 |
| Start date | Sep 1, 2003 |
| Completion | Jan 1, 2004 |
| First posted | Apr 18, 2007 |
| Last update posted | Apr 18, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: